Literature DB >> 33567936

Elevated circulating growth differentiation factor 15 is related to decreased heart rate variability in chronic kidney disease patients.

Lulu Wang1, Jing Luo1, Wenjin Liu2, Xiaoqin Huang1, Jie Xu1, Yang Zhou1, Lei Jiang1, Junwei Yang1.   

Abstract

BACKGROUND: Growth differentiation factor 15(GDF15) is a distant member of the superfamily of the transforming growth factor beta (TGF-β). It has been established that increased GDF15 levels are associated with an increased risk of cardiovascular disease. However, the detail effect of GDF15 on cardiovascular system in patients with chronic kidney disease (CKD) needs detail analysis.
METHODS: Patients with CKD who did not need dialysis were enrolled in the study. Blood pressure (BP), endothelial function, pulse wave velocity (PWV) and heart rate variability (HRV) were taken in all subjects. Plasma GDF15 concentration was measured by an enzyme-linked immunosorbent assay.
RESULTS: Among the 355 participants, the mean age was 57.4 (±14.2) years old and the mean estimated glomerular filtration rate (eGFR) was 50.1 (±33.2) mL/min/1.73m2. The average plasma GDF15 level was 1394.7 (±610.1) pg/mL. Higher GDF15 concentrations were significantly associated with decreased eGFR and increased urine protein-to-creatinine ratio (uPCR). In multivariable models, after adjusting for potential confounders, plasma GDF15 has negative concerning with HRV parameters including the standard deviation of the normal-to-normal (NN) interval (SDNN), the square root of the mean of the sum of the squares of differences between adjacent NN intervals (RMSSD) and Triangular Index.
CONCLUSION: We observed there was a link between increased plasma of GDF15 and decreased HRV. The mechanisms and prediction of GDF15 in the cardiovascular disease with CKD needs further discussion and study.

Entities:  

Keywords:  GDF15; chronic kidney disease; heart rate variability

Year:  2021        PMID: 33567936      PMCID: PMC7889148          DOI: 10.1080/0886022X.2021.1880938

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  33 in total

1.  Heart Rate Variability Predicts Major Adverse Cardiovascular Events and Hospitalization in Maintenance Hemodialysis Patients.

Authors:  Jiun-Chi Huang; I-Ching Kuo; Yi-Chun Tsai; Jia-Jung Lee; Lee-Moay Lim; Szu-Chia Chen; Yi-Wen Chiu; Jer-Ming Chang; Hung-Hun Chen
Journal:  Kidney Blood Press Res       Date:  2017-03-17       Impact factor: 2.687

2.  Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease.

Authors:  Samuel N Breit; Juan J Carrero; Vicky Wang-Wei Tsai; Nasreen Yagoutifam; Wei Luo; Tamara Kuffner; Asne R Bauskin; Liyun Wu; Lele Jiang; Peter Barany; Olof Heimburger; Mary-Ann Murikami; Fred S Apple; Christopher P Marquis; Laurence Macia; Shu Lin; Amanda Sainsbury; Herbert Herzog; Matthew Law; Peter Stenvinkel; David A Brown
Journal:  Nephrol Dial Transplant       Date:  2011-09-22       Impact factor: 5.992

3.  Depressed cardiac autonomic modulation in patients with chronic kidney disease.

Authors:  Carlos Alberto de Oliveira; Helio Lima de Brito Junior; Marcus Gomes Bastos; Felipe Gomes de Oliveira; Thais Gomes Casali; Tiago Costa Bignoto; Natalia Maria da Silva Fernandes; Antonio Fernando de Castro Alves Beraldo; Rogério Baumgratz de Paula
Journal:  J Bras Nefrol       Date:  2014 Apr-Jun

4.  GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand.

Authors:  Linda Yang; Chih-Chuan Chang; Zhe Sun; Dennis Madsen; Haisun Zhu; Søren B Padkjær; Xiaoai Wu; Tao Huang; Karin Hultman; Sarah J Paulsen; Jishu Wang; Anne Bugge; Jane Boesen Frantzen; Per Nørgaard; Jacob Fuglsbjerg Jeppesen; Zhiru Yang; Anna Secher; Haibin Chen; Xun Li; Linu Mary John; Bing Shan; Zhenhua He; Xiang Gao; Jing Su; Kristian T Hansen; Wei Yang; Sebastian Beck Jørgensen
Journal:  Nat Med       Date:  2017-08-28       Impact factor: 53.440

5.  The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.

Authors:  Paul J Emmerson; Feng Wang; Yong Du; Qian Liu; Richard T Pickard; Malgorzata D Gonciarz; Tamer Coskun; Matthew J Hamang; Dana K Sindelar; Kimberly K Ballman; Lisa A Foltz; Avinash Muppidi; Jorge Alsina-Fernandez; Gavin C Barnard; Jason X Tang; Xilin Liu; Xudong Mao; Robert Siegel; John H Sloan; Pamela J Mitchell; Bei B Zhang; Ruth E Gimeno; Bei Shan; Xinle Wu
Journal:  Nat Med       Date:  2017-08-28       Impact factor: 53.440

6.  Targeting Obesity and Cachexia: Identification of the GFRAL Receptor-MIC-1/GDF15 Pathway.

Authors:  Samuel N Breit; Vicky Wang-Wei Tsai; David A Brown
Journal:  Trends Mol Med       Date:  2017-11-09       Impact factor: 11.951

7.  Heart rate variability and lifetime risk of cardiovascular disease: the Atherosclerosis Risk in Communities Study.

Authors:  Yasuhiko Kubota; Lin Y Chen; Eric A Whitsel; Aaron R Folsom
Journal:  Ann Epidemiol       Date:  2017-10-03       Impact factor: 3.797

8.  Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery.

Authors:  Beatriz Bermúdez; Sergio López; Yolanda M Pacheco; José Villar; Francisco J G Muriana; Jöerg D Hoheisel; Andrea Bauer; Rocío Abia
Journal:  Cardiovasc Res       Date:  2008-03-21       Impact factor: 10.787

9.  Chronic kidney disease and 10-year risk of cardiovascular death.

Authors:  Martin J Holzmann; Axel C Carlsson; Niklas Hammar; Torbjörn Ivert; Göran Walldius; Ingmar Jungner; Per Wändell; Johan Ärnlöv
Journal:  Eur J Prev Cardiol       Date:  2015-11-05       Impact factor: 7.804

10.  hNAG-1 increases lifespan by regulating energy metabolism and insulin/IGF-1/mTOR signaling.

Authors:  Xingya Wang; Kali Chrysovergis; Justin Kosak; Grace Kissling; Mike Streicker; Glenda Moser; Ruifang Li; Thomas E Eling
Journal:  Aging (Albany NY)       Date:  2014-08       Impact factor: 5.682

View more
  2 in total

1.  Negative Regulators of Inflammation Response to the Dynamic Expression of Cytokines in DF-1 and MDCK Cells Infected by Avian Influenza Viruses.

Authors:  Bingqian Zhao; Huizi Li; Suilan Cao; Wenxia Zhong; Baojian Li; Weixin Jia; Zhangyong Ning
Journal:  Inflammation       Date:  2021-09-28       Impact factor: 4.092

2.  Association Between Circulating GDF-15 and Cardio-Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS Trial.

Authors:  Taha Sen; Jingwei Li; Brendon L Neuen; Clare Arnott; Bruce Neal; Vlado Perkovic; Kenneth W Mahaffey; Wayne Shaw; William Canovatchel; Michael K Hansen; Hiddo J L Heerspink
Journal:  J Am Heart Assoc       Date:  2021-12-02       Impact factor: 6.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.